API, Formulation and Research
Founded in 2003, the Hyderabad based MSN Labs is one of the fastest growing research-based pharmaceutical company in India. Boasting a diverse product portfolio, with multiple products in the market and in the pipeline, MSN has 3 Formulation & 8 API facilities and an integrated R&D Center located in Hyderabad. The facilities have PIC/S, USFDA, EU:GMP, WHO:Geneva, Invima and many other global approvals. MSN has launched 1st-in-the-World Generics for 11 state-of-the-art-medicines at affordable prices, filed 220 Patents, 303 DMFs/CEPs and 1500 Formulation Dossiers. With a product portfolio covering 35 major therapies including Oncology, MSN has won the trust of more than 250 customers across 65 countries around the globe covering the US, Europe, Latin America, Middle-East, Asia Pacific, Africa and CIS markets. Innovation & speed form the core of our business strategy. Pro-active marketing, robust IP strategy, innovative R&D expertise, dynamic SCM, insight driven IT and world class capabilities are our ingredients to success. With a dedicated & experienced team of over 3000, the organizational environment at MSN integrates multiple disciplines and functions by exhaustive communication of goals and objectives through technology and values of Integrity, Imagination & Innovation. We have grown from USD 0 to USD 210 million in just 10 years. With an outstanding workforce, cutting-edge science, state-of-the-art technology base and knowledge intensive initiatives, we are working on innovative solutions for tomorrow's healthcare problems.